|
4 Maguire Rd. Lexington, MA 02421 MA Tel. 617-503-6500 Fax 617-503-6501 |
Type: Public
On the web:
http://www.curis.com
Employees:
35
Employee growth: 9.4%
Curis's cancer patients and Sega's gamers might one day have an unlikely hero in common: Sonic the Hedgehog. Drug development firm Curis is studying hedgehog signaling pathways (including the sonic hedgehog pathway, named after the Sega mascot) to find treatments for oncology ailments and other conditions. Such signaling pathways regulate tissue growth and repair, and the company is looking for ways to either stimulate them or slow them down as a means of treating disease. Curis is collaborating with Genentech to develop cancer drugs using hedgehog pathways. The company also has internal development programs for cancer treatments using other signaling pathways.
Key numbers for fiscal year ending December, 2011:
Sales: $14.8M
One year growth: (7.7%)
Net income: ($9.9)M
Officers:
Chairman: James R. McNab Jr.
President, CEO, and Director: Daniel R. (Dan) Passeri
CFO, COO and Secretary: Michael P. (Mike) Gray
Competitors:
Exelixis
Infinity Pharmaceuticals
Pfizer
File maintained by the U.S. Postal Service that lists all of the approximately 570,000 carrier routes by street name or ranges of street numbers. It is used by large-volume mailers to append the carrier route to the name and address records on their mailing lists so that mailings can be presorted accordingly, thereby earning a postage discount. See also address coding guide; carrier route coding; carrier route presort; carrier route qualified.
Halted. Market Data powered by QuoteMedia, fundamentals by Morningstar. Terms of use.
Read more